LUCA MARRI

@ospedalesanmartino.it

M.D. in Clinical Immunology.
Clinical Immunology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

LUCA MARRI


               Download Compact PDF  
https://researchid.co/luca_marri_93

RESEARCH, TEACHING, or OTHER INTERESTS

Immunology and Allergy, Internal Medicine, Cell Biology
9

Scopus Publications

153

Scholar Citations

3

Scholar h-index

1

Scholar i10-index

Scopus Publications

  • Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence multicenter study
    Stefania Peruzzo, Luca Tagliafico, Silvia Ottaviani, Federica Della Rovere, Carlo Marani, Michela Mattioli, Alessio Nencioni, Fiammetta Monacelli, Alberto Ballestrero, Alberto Pilotto, Alberto Sulli, Alessandro Ronda, Alì Jafal, Andrea Balestra, Andrea Bellodi, Andrea Giusti, Andrea Guastalla, Angelo Schenone, Anna Maria Gatti, Babette Dijk, Barbara Bonino, Barbara Senesi, Camilla Prete, Carmen Pizzorni, Christian Cascio, Cinzia Bottaro, Clarissa Ciaramidaro, Clarissa Musacchio, Claudia Bighin, Cristina Papandrea, Debora Tiso, Domenico Cerminara, Edoardo Giovanni Giannini, Ekaterini Zigoura, Elena Bogliacino, Elena Page, Eleonora Arboscello, Elisa Caratto, Emanuela Barisione, Emanuele Angelucci, Erica Tavella, Fabio Ferrando, Fabio Guolo, Fabrizio Montecucco, Federica Boeri, Federica Gandolfo, Federica Piccardo, Federico Barà, Federico Carbone, Federico Gentilini, Federico Molinelli, Federico Santolini, Francesca Caserza, Francesca Fezza, Francesca Chiara Viazzi, Francesca Dall’Acqua, Francesca Dellacasa, Francesca Gargiulo, Francesca Specchia, Francesca Tricerri, Francesco Ottonello, Francesco Torre, Fulvio Braido, Giancarlo Antonucci, Giulia Bartalucci, Giulia Bozzo, Guglielmo Bruzzone, Ilaria Indiano, Irene Giannubilo, Laura Camia, Laura De Mattei, Lidia Piscina, Linda Kratochwilla, Lisa Cammalleri, Lorenzo Ieni, Lorenzo Stellino, Luca Marri, Lucia Del Mastro, Margherita Milone, Maria Carla Ghinatti, Maria Chiara Stimolo, Maria Concetta Scirocco, Maria Corina Plaz Torres, Mariapaola Segalerba, Maria-Paola Fiamingo, Marina De Candia, Marta Canepa, Marta Ferrari, Marta Ponzano, Massimo Lemoli Roberto, Massimo Luzzani, Matteo Formica, Matteo Pardini, Mimosa Lakrandi Sulthanagoda Manage, Mona Mahmoud, Monica Pizzonia, Monica Pomata, Nicholas Bardi, Paola Campodonico, Paola Cianciosi, Paolo Barbera, Paolo Borro, Paolo Moscatelli, Patrizia Costelli, Pirola Valeria, Pontremoli Roberto, Raffaele De Palma, Riccardo Balzano, Roberta Gonella, Romina Custureri, Romina Rebizzo, Rosetta Femia, Sabrina Piredda, Sara Garaboldi, Sara Guizzetti, Selena Dasso, Serafina Mammoliti, Silvia Podestà, Silvia Sambuceti, Silvia Stefanelli, Simone Dini, Simone Isoppo, Stefania Sciallero, Stefania Vecchio, Teresita Aloè, Tommaso Granello, Ugo Compagnone, Umberto Tortorolo, Valentina Beccati, Veronica Carpaneto
    Maturitas, 2026
    OBJECTIVES AND BACKGROUND: Older adults with multimorbidity and frailty frequently require palliative care, yet prescribing practices often remain focused on primary or secondary disease prevention rather than symptom relief. Polypharmacy and potentially inappropriate medications (PIMs) may undermine quality of life and alter the benefit-to-harm ratio in this population. This study evaluated the prevalence of polypharmacy, pharmacological prescribing patterns and PIMs in hospitalized older adults requiring palliative care. STUDY DESIGN: This nested study of the Italian multicenter point-prevalence study (Palliative Care 2.0) included patients aged ≥65 years from three metropolitan hospitals and three nursing homes in Genoa, Liguria, Italy. Needs for palliative care were assessed using the NECPAL CCOMS-ICO© tool and those categorized as 'positive' were staged I-III. Polypharmacy (≥5 drugs) and five PIMs were evaluated according to STOPP-Frail criteria. Data were analyzed through appropriate hypothesis tests (Mann-Whitney, Anova, chi-squared) comparing NECPAL positive and negative participants, while associations with number of PIMs were explored through regression analysis. RESULTS: Of 558 patients initially screened, 294 were administered the NECPAL tool, of whom 254 (45.5% of the sample screened) had PC needs (mean age 85 ± 11 years; 61% female). Polypharmacy was reported in 93.9% (276/294), with a median of 9 drugs (IQR 5). PIMs were identified in 68.2% of patients and were strongly associated with polypharmacy (p < 0.001), but were less common in nursing home residents compared with hospital patients (p < 0.001). Drug burden and the prevalence of PIMs did not decline with advancing NECPAL stage, except for increased antidiabetic use in stage III. CONCLUSIONS: Polypharmacy and PIM use are highly prevalent in older adults who require palliative care, persisting even in advanced stages of illness. Current practice appears to fall short of both effective deprescribing and fully aligning pharmacological therapy with goals of care and overall quality of life. Systematic efforts to align pharmacotherapy with patients' care goals and clinical status are essential to minimize harm and promote quality of life in the final stages of life.
  • Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications
    Anna Maria Raiola, Paola Contini, Massimiliano Gambella, Luca Barabino, Stefania Bregante, Carmen di Grazia, Alida Dominietto, Anna Ghiso, Andrea Guastalla, Luca Marri, Alberto Serio, Silvia Luchetti, Riccardo Varaldo, Antonella Laudisi, Giulia Francia, Monica Passannante, Federico Ivaldi, Alessandra Bo, Raffaele De Palma, Emanuele Angelucci
    American Journal of Hematology, 2026
    Cryopreservation of allogeneic peripheral blood stem cells was widely adopted during the SARS‐CoV‐2 pandemic. We evaluated transplant‐related complications and graft product composition in a retrospective ( n = 62) and prospective ( n = 47) series of patients transplanted from an HLA‐identical donor comparing cryopreserved ( n = 50) versus fresh ( n = 59) peripheral blood stem cell grafts. Primary endpoints were hematological reconstitution and cumulative incidence of grade II–IV acute graft versus host disease. Median times to neutrophil and platelet recovery were longer in the cryopreserved group compared with the fresh group: 18 vs. 16 days ( p &lt; 0.001) and 20 vs. 14 days ( p &lt; 0.001), respectively. The cumulative incidence of grade II–IV acute graft versus host disease at day 100 and of poor graft function at 1 year was significantly higher in the cryopreserved group: 34% vs. 10.1%, ( p = 0.0017) and 20% vs. 1.6% ( p &lt; 0.001), respectively. To characterize immune cell profiles in fresh and cryopreserved samples, a representative subset was analyzed by mass cytometry, revealing a higher number of T‐cell populations known to modulate immune responses and promote graft engraftment in fresh samples. Thus, cryopreservation of allogeneic peripheral blood stem cells is associated with increased incidence of acute graft versus host disease and poor graft function.
  • Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions
    Luca Marri, Paola Contini, Federico Ivaldi, Chiara Schiavi, Ottavia Magnani, Chiara Vassallo, Andrea Guastalla, Noemi Traversone, Davide Deraco, Claudia Angelini, Genny Del Zotto, Raffaele De Palma, Andrea De Maria
    Immunology Letters, 2025
    BACKGROUND: Splenomegaly represents a frequent non-infectious manifestation in Common Variable Immunodeficiency (CVID) and associates with specific clinical and immunophenotypic characteristics. OBJECTIVE: To investigate the association between splenomegaly, infections, and immunophenotype in CVID patients. METHODS: A cohort of 32 CVID patients (13 with splenomegaly) was enrolled. Infectious workup encompassed a detailed medical history and data derived from routine diagnostic assessments including specific virological analysis of blood and stool samples, and QuantiFERON assay for tuberculosis. Immunophenotype was assessed by multiparametric flow cytometry. Statistical analyses were performed using Prism and Jamovi software. RESULTS: ), and increased T cell activation as defined by HLA-DR/CD69/CD38 expression. CONCLUSION: sCVID of NK cell, inflammatory precursor and T cell imbalances suggests a possible combined cellular defect at precursor level in a subset of sCVID patients. When integrated into everyday clinical management, CMV viraemia could become a useful additional parameter for patient characterization and stratification.
  • Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome
    Mehdi Benamar, Peggy S. Lai, Ching‐Ying Huang, Qian Chen, Fatma Betul Oktelik, Paola Contini, Muyun Wang, Daniel Okin, Elena Crestani, Jason Fong, Tsz Man Chan Fion, Merve Nida Gokbak, Hani Harb, Wanda Phipatanakul, Luca Marri, Chiara Vassallo, Andrea Guastalla, Minsik Kim, Hui‐Yu Sui, Lorenzo Berra, Marcia B. Goldberg, Claudia Angelini, Raffaele De Palma, Talal A. Chatila
    Allergy European Journal of Allergy and Clinical Immunology, 2025
    BackgroundImmune dysregulation and SARS‐CoV‐2 plasma viremia have been implicated in fatal COVID‐19 disease. However, how these two factors interact to shape disease outcomes is unclear.MethodsWe carried out viral and immunological phenotyping on a prospective cohort of 280 patients with COVID‐19 presenting to acute care hospitals in Boston, Massachusetts and Genoa, Italy between June 1, 2020 and February 8, 2022. Disease severity, mortality, plasma viremia, and immune dysregulation were assessed. A mouse model of lethal H1N1 influenza infection was used to analyze the therapeutic potential of Notch4 and pyroptosis inhibition in disease outcome.ResultsStratifying patients based on %Notch4+ Treg cells and/or the presence of plasma viremia identified four subgroups with different clinical trajectories and immune phenotypes. Patients with both high %Notch4+ Treg cells and viremia suffered the most disease severity and 90‐day mortality compared to the other groups even after adjusting for baseline comorbidities. Increased Notch4 and plasma viremia impacted different arms of the immune response in SARS‐CoV‐2 infection. Increased Notch4 was associated with decreased Treg cell amphiregulin expression and suppressive function whereas plasma viremia was associated with increased monocyte cell pyroptosis. Combinatorial therapies using Notch4 blockade and pyroptosis inhibition induced stepwise protection against mortality in a mouse model of lethal H1N1 influenza infection.ConclusionsThe clinical trajectory and survival outcome in hospitalized patients with COVID‐19 is predicated on two cardinal factors in disease pathogenesis: viremia and Notch4+ Treg cells. Intervention strategies aimed at resetting the immune dysregulation in COVID‐19 by antagonizing Notch4 and pyroptosis may be effective in severe cases of viral lung infection.
  • Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients
    Luca Marri, Paola Contini, Federico Ivaldi, Chiara Schiavi, Ottavia Magnani, Chiara Vassallo, Andrea Guastalla, Noemi Traversone, Claudia Angelini, Genny Del Zotto, Andrea De Maria, Raffaele De Palma
    Journal of Clinical Immunology, 2024
    Purpose Common Variable Immunodeficiency (CVID) is characterized by hypogammaglobulinemia and failure of specific antibody production due to B-cell defects. However, studies have documented various T-cell abnormalities, potentially linked to viral complications. The frequency of Cytomegalovirus (CMV) replication in CVID cohorts is poorly studied. To address this gap in knowledge, we set up an observational study with the objectives of identifying CVID patients with active viraemia (CMV, Epstein-Barr virus (EBV)), evaluating potential correlations with immunophenotypic characteristics, clinical outcome, and the dynamic progression of clinical phenotypes over time. Methods 31 CVID patients were retrospectively analysed according to viraemia, clinical and immunologic characteristics. 21 patients with non CVID humoral immunodeficiency were also evaluated as control. Results Active viral replication of CMV and/or EBV was observed in 25% of all patients. CMV replication was detected only in CVID patients (16%). CVID patients with active viral replication showed reduced HLA-DR+ NK counts when compared with CMV-DNA negative CVID patients. Viraemic patients had lower counts of LIN−DNAMbright and LIN−CD16+ inflammatory lymphoid precursors which correlated with NK-cell subsets. Analysis of the dynamic progression of CVID clinical phenotypes over time, showed that the initial infectious phenotype progressed to complicated phenotypes with time. All CMV viraemic patients had complicated disease. Conclusion Taken together, an impaired production of inflammatory precursors and NK activation is present in CVID patients with active viraemia. Since “Complicated” CVID occurs as a function of disease duration, there is need for an accurate evaluation of this aspect to improve classification and clinical management of CVID patients.
  • Clinical Characteristics of Systemic Lupus Erythematosus in Caucasians and Latin American Hispanics: Data from a Single Tertiary Center
    Luca Marri, Chiara Vassallo, Pasquale Esposito, Luca Bottaro, Raffaele De Palma, Simone Negrini
    Autoimmune Diseases, 2024
    Background. Different studies report that systemic lupus erythematosus (SLE) tends to have a more aggressive course in Hispanic patients. In this study, we analysed epidemiologic, clinical, and laboratory characteristics in a cohort of Hispanic and Caucasian lupus patients in the context of Italian health service, which provides free access to care to all citizens, thus mitigating the impact of socioeconomic factors that negatively influence the course of the disease in ethnic minorities. Methods. This single‐center retrospective study was conducted at the San Martino Hospital “Lupus Clinic” in Genoa, Italy. Patients ≥18 years with a confirmed diagnosis of SLE and definite ethnicity (Hispanic or Caucasian) were recruited. Results. A total of 126 patients (90 Caucasians and 36 Hispanics) were enrolled. We compared epidemiologic characteristics, clinical features, autoantibodies profile, and treatment options without evidencing any statistically significant difference between the two groups, except for disease duration, which was higher in the Caucasian group (20.4 years versus 14.2 years in the Hispanic group, P = 0.002) and SLICC damage index, which was greater in Caucasian patients (2.11 versus 1.88 in Hispanics, P = 0.037), but this difference was no longer significant after correction for disease duration (P = 0.096). Conclusions. In our cohort, Hispanic ethnicity is not associated with worse disease features and outcomes. Therefore, we speculated that socioeconomic factors, in particular, free access to healthcare, might be more relevant in influencing the course of the disease than genetic background.
  • Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies
    Chiara Schiavi, Luca Marri, Simone Negrini
    Thrombosis Journal, 2023
    Systemic lupus erythematosus (SLE) patients have an increased risk of cardiovascular disease and thrombotic events, and the presence of antiphospholipid antibodies further raises the risk of these complications. Here we report a case of a patient with SLE and triple positivity for antiphospholipid antibodies who developed a popliteal artery thrombosis in the context of a severe hyperhomocysteinemia after the introduction of methotrexate (MTX) treatment. MTX is one of the most prescribed medications for a wide spectrum of autoimmune diseases, including SLE. On the other hand, by interfering with folate metabolism, it may induce hyperhomocysteinemia, which, in turn, may increase the risk of vascular complications. Current recommendations suggest screening and, when possible, treating classical and disease-related cardiovascular risk factors in all lupus patients. Based on what observed in our case, we suggest a follow-up of homocysteine levels after the introduction of drugs capable of inducing hyperhomocysteinemia, such as MTX, in SLE patients at high cardiovascular risk.
  • Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections
    Hani Harb, Mehdi Benamar, Peggy S. Lai, Paola Contini, Jason W. Griffith, Elena Crestani, Klaus Schmitz-Abe, Qian Chen, Jason Fong, Luca Marri, Gilberto Filaci, Genny Del Zotto, Novalia Pishesha, Stephen Kolifrath, Achille Broggi, Sreya Ghosh, Metin Yusuf Gelmez, Fatma Betul Oktelik, Esin Aktas Cetin, Ayca Kiykim, Murat Kose, Ziwei Wang, Ye Cui, Xu G. Yu, Jonathan Z. Li, Lorenzo Berra, Emmanuel Stephen-Victor, Louis-Marie Charbonnier, Ivan Zanoni, Hidde Ploegh, Gunnur Deniz, Raffaele De Palma, Talal A. Chatila
    Immunity, 2021
  • Recurrence of COVID-19 related symptoms and viral detection in a patient discharged after complete recovery and test negativization
    Chiara Vassallo, Francesca Pupo, Luca Marri, Chiara Schiavi, Francesca Giusti, Monica Greco, Simone Negrini, Raffaele De Palma, Andrea Guastalla
    Italian Journal of Medicine, 2021
    Since the novel coronavirus disease 2019 (COVID-19) has been declared a pandemic, the possibility of recurrence of the disease after recovery has become a debated issue. We report a case of an 84-years-old male patient who was admitted to our hospital for dyspnea and fever. Lab and clinical workout showed that he had COVID-19. After a full recovery of symptoms and a double negative nasopharyngeal swab of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) by realtime polymerase chain reaction assay, he was discharged from the hospital. One month later, he developed dyspnea and fever again with lung involvement. Surprisingly, the nasopharyngeal swab of SARS-CoV-2 was positive. Since he denied contacts with confirmed or suspected cases of COVID-19, he probably experienced a reactivation of a persistent infection. The failed eradication of the virus could depend on both virus’ escape mechanisms and dysfunctional immune response. Further studies are needed to confirm the hypothesis of viral reactivation and identify signs of an incomplete clearance.

RECENT SCHOLAR PUBLICATIONS

  • Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications
    AM Raiola, P Contini, M Gambella, L Barabino, S Bregante, C Di Grazia, ...
    American Journal of Hematology 101 (5), 1036-1044 , 2026
    2026
  • Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence …
    S Peruzzo, L Tagliafico, S Ottaviani, F Della Rovere, C Marani, M Mattioli, ...
    Maturitas, 108928 , 2026
    2026
  • Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions
    L Marri, P Contini, F Ivaldi, C Schiavi, O Magnani, C Vassallo, A Guastalla, ...
    Immunology Letters 276, 107058 , 2025
    2025
  • Notch4 regulatory T cells and SARS‐CoV‐2 viremia shape COVID19 survival outcome
    M Benamar, PS Lai, CY Huang, Q Chen, FB Oktelik, P Contini, M Wang, ...
    Allergy 80 (2), 557-569 , 2025
    2025
    Citations: 3
  • Evaluation of frequency of CMV replication and disease complications reveals new cellular defects and a time dependent pattern in CVID patients
    L Marri, P Contini, F Ivaldi, C Schiavi, O Magnani, C Vassallo, A Guastalla, ...
    Journal of Clinical Immunology 44 (6), 142 , 2024
    2024
    Citations: 4
  • Clinical Characteristics of Systemic Lupus Erythematosus in Caucasians and Latin American Hispanics: Data from a Single Tertiary Center
    L Marri, C Vassallo, P Esposito, L Bottaro, R De Palma, S Negrini
    Autoimmune Diseases 2024 (1), 5593302 , 2024
    2024
    Citations: 2
  • Analisi della replicazione virale di Citomegalovirus e del virus di Epstein-Barr su sangue periferico in una coorte di pazienti affetti da Immunodeficienza Comune Variabile …
    L Marri
    Università degli studi di Genova , 2023
    2023
  • Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies
    C Schiavi, L Marri, S Negrini
    Thrombosis journal 21 (1), 113 , 2023
    2023
    Citations: 7
  • Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections
    H Harb, M Benamar, PS Lai, P Contini, JW Griffith, E Crestani, ...
    Immunity 54 (6), 1186-1199. e7 , 2021
    2021
    Citations: 136
  • Recurrence of COVID-19 related symptoms and viral detection in a patient discharged after complete recovery and test negativization
    C Vassallo, F Pupo, L Marri, C Schiavi, F Giusti, M Greco, S Negrini, ...
    Italian Journal of Medicine 15, 67-70 , 2021
    2021
    Citations: 1

MOST CITED SCHOLAR PUBLICATIONS

  • Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections
    H Harb, M Benamar, PS Lai, P Contini, JW Griffith, E Crestani, ...
    Immunity 54 (6), 1186-1199. e7 , 2021
    2021
    Citations: 136
  • Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies
    C Schiavi, L Marri, S Negrini
    Thrombosis journal 21 (1), 113 , 2023
    2023
    Citations: 7
  • Evaluation of frequency of CMV replication and disease complications reveals new cellular defects and a time dependent pattern in CVID patients
    L Marri, P Contini, F Ivaldi, C Schiavi, O Magnani, C Vassallo, A Guastalla, ...
    Journal of Clinical Immunology 44 (6), 142 , 2024
    2024
    Citations: 4
  • Notch4 regulatory T cells and SARS‐CoV‐2 viremia shape COVID19 survival outcome
    M Benamar, PS Lai, CY Huang, Q Chen, FB Oktelik, P Contini, M Wang, ...
    Allergy 80 (2), 557-569 , 2025
    2025
    Citations: 3
  • Clinical Characteristics of Systemic Lupus Erythematosus in Caucasians and Latin American Hispanics: Data from a Single Tertiary Center
    L Marri, C Vassallo, P Esposito, L Bottaro, R De Palma, S Negrini
    Autoimmune Diseases 2024 (1), 5593302 , 2024
    2024
    Citations: 2
  • Recurrence of COVID-19 related symptoms and viral detection in a patient discharged after complete recovery and test negativization
    C Vassallo, F Pupo, L Marri, C Schiavi, F Giusti, M Greco, S Negrini, ...
    Italian Journal of Medicine 15, 67-70 , 2021
    2021
    Citations: 1
  • Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications
    AM Raiola, P Contini, M Gambella, L Barabino, S Bregante, C Di Grazia, ...
    American Journal of Hematology 101 (5), 1036-1044 , 2026
    2026
  • Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence …
    S Peruzzo, L Tagliafico, S Ottaviani, F Della Rovere, C Marani, M Mattioli, ...
    Maturitas, 108928 , 2026
    2026
  • Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions
    L Marri, P Contini, F Ivaldi, C Schiavi, O Magnani, C Vassallo, A Guastalla, ...
    Immunology Letters 276, 107058 , 2025
    2025
  • Analisi della replicazione virale di Citomegalovirus e del virus di Epstein-Barr su sangue periferico in una coorte di pazienti affetti da Immunodeficienza Comune Variabile …
    L Marri
    Università degli studi di Genova , 2023
    2023